Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY,  Australia,  May  28,  2021 -  Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of…

Continue ReadingBeroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
Read more about the article Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
Beroni ’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

  • Post author:
  • Post category:2021
  • Post comments:0 Comments

NEW YORK and SYDNEY, April 27, 2021, Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the notification that its SARS-CoV-2 Antigen Test…

Continue ReadingBeroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit

Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

  • Post author:
  • Post category:2020
  • Post comments:0 Comments

On December 21, 2020, Australia, Beroni Group Limited (“Beroni Group”) announces it has received notification from its European Authorized Representative, CMC Medical Devices & Drugs SL, that its newly developed…

Continue ReadingBeroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

  • Post author:
  • Post category:2020
  • Post comments:0 Comments

NEW YORK and SYDNEY, October 19, 2020, Beroni Group (“Beroni”) announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation (“GenScript”), a leading global biotechnology company.…

Continue ReadingBeroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19